The changing epidemiology of bacteraemias in Europe: Trends from the European antimicrobial resistance surveillance system

Clinical Microbiology and Infection

Volumn 19, Issue 9, 2013, Pages 860-868

  de Kraker, M E A ^a,b   Jarlier, V ^c   Monen, J C M ^a   Heuer, O E ^d   van de Sande, N ^e   Grundmann, H ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c SORBONNE UNIVERSITÉ   (France)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

Antimicrobial resistance; Bacteraemia; Enterococcus faecalis; Enterococcus faecium; Epidemiology; Escherichia coli; Europe; Staphylococcus aureus; Streptococcus pneumoniae; Trend

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; DISEASE SURVEILLANCE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EUROPE; HUMAN; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84882595540     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12028     Document Type: Article

References (28)

1. De Kraker MEA, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8: e1001104.
2. Allard C, Carignan A, Bergevin M et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008; 14: 421-428.
3. Wilson J, Elgohari S, Livermore DM et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011; 17: 451-458.
4. Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect 2011; 17: 513-518.
5. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
6. Stamm AM, Long MN, Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 1993; 21: 70-74.
7. Morgan M, Salmon R, Evans-Williams D, Hosein I, Looker DN. Resistance to methicillin in isolates of Staphylococcus aureus from blood and cerebrospinal fluid in Wales, 1993-1997. J Antimicrob Chemother 1999; 44: 541-544.
8. Jernigan JA, Clemence MA, Stott GA et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16: 686-696.
9. Boyce JM, White RL, Spruill EY. Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J Infect Dis 1983; 148: 763.
10. Giske CG, Cornaglia G. Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future. Drug Resist Updat 2010; 13: 93-98.
11. EARSS-MT, Advisory Board, and National Representatives. EARSS annual report 2008. On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. 2009. Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2008_EARSS_Annual_Report.pdf (last accessed 25 September 2012).
12. EARSS-MT. European Centre for Disease prevention and Control EARS-Net Reporting Protocol 2010. 2010. Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2010_EARS-Net_Reporting%20Protocol.pdf (last accessed 25 September 2012).
13. EARSS-MT, Advisory Board, and National Representatives. EARSS annual report 2004. On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis. 2005. Available at: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2004_EARSS_Annual_Report.pdf (last accessed 25 September 2012).
14. Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013; 19: 465-471.
15. Marcos M, Soriano A, Inurrieta A et al. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens. J Antimicrob Chemother 2011; 66: 2119-2125.
16. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008; 27: 1045-1051.
17. Polder JJ, Bonneux L, Meerding WJ, van der Maas PJ. Age-specific increases in health care costs. Eur J Public Health 2002; 12: 57-62.
18. Preyra C. Coding response to a case-mix measurement system based on multiple diagnoses. Health Serv Res 2004; 39: 1027-1045.
19. Swafford S. Invasive devices increase risk of infection. BMJ 1997; 314: 1503.
20. Shepard BD, Gilmore MS. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect 2002; 4: 215-224.
21. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-828.
22. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010; 23: 320-326.
23. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-885.
24. Deurenberg RH, Nulens E, Valvatne H et al. Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region. Emerg Infect Dis 2009; 15: 727-734.
25. Duerden B. Controlling healthcare-associated infections in the NHS. Clin Med 2008; 8: 140-143.
26. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003; 36: 1433-1437.
27. Jarlier V, Trystram D, Brun-Buisson C et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010; 170: 552-559.
28. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?J Antimicrob Chemother 2011; 66: 2199-2214.